Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 October, 2019 22:54 IST
Aurobindo Pharma completes acquisition of businesses in 5 European countries
Source: IRIS | 11 Feb, 2019, 11.05AM
Comments  |  Post Comment

Aurobindo Pharma, a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, today announced that it has closed the acquisition of Apotex's commercial operations and certain supporting infrastructure in five European countries.

The binding agreement to acquire five of Apotex' European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorizations and dossier license rights in Poland, the Czech Republic, the Netherlands (including the manufacturing facility in Leiden), Spain and Belgium was announced on July 14, 2018.

This announcement does not constitute a recommendation to shareholders or potential investors.

Jefferies International acted as sole financial advisor and Herbert Smith Freehills LLP acted as legal counsel to Aurobindo. Ernst & Young, India provided financial due diligence services.

Shares of the company declined Rs 0.55, or 0.07%, to trade at Rs 760.10. The total volume of shares traded was 25,043 at the BSE (10.07 a.m., Monday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Could not connect: Too many connections